DMEA
Meet our team at DMEA 2024 from April 09 - 11
Your company is already operating in Germany and you would now like to export worldwide?
Meet our team at DMEA 2024 from April 09 - 11
The mood in German pharmaceuticals is bright, with companies looking to increase investment.
Germany's life sciences sector is proving attractive to start-up investors and international health companies alike.
Germany's medical technology sector secured more than EUR 2 billion in investment in 2021, with start-up companies and larger corporations alike developing great innovations.
Germany's life sciences sector was the top medical device FDI destination in 2019 and 2020. Companies including Bayer and BioNTech are also expanding their footprint in the country.
Start-ups and scale-ups from Germany are constantly in the headlines. Sometimes the efforts of smaller start-ups go unnoticed. Here we showcase selected start-up developments worthy of attention.